Redx Pharma Plc (LON:REDX)

Redx Pharma Plc (LON:REDX)


Share Price
10.00 p
Change
-2 (-16.67 %)
Market Cap
£12.65 m
Proactive Investors - Run By Investors For Investors

Redx Pharma Plc

Focused on the development of novel medicines to validated anti-cancer and fibrosis targets in areas of unmet need

Redx Pharma uses its proven drug discovery expertise to generate development candidates that it will take into the clinic and then partner. The company’s product development strategy has three interrelated components:

Cancer: RXC004, our lead clinical asset
Build on...

EPIC: REDX
Market: AIM:REDX
52-week High/Low: 14.84p / 4.75p
Sector: Pharma & Biotech
Market Cap: £12.65 m
Website: www.redxpharma.com
col 3
col 4
col 5
col 6

Big Picture – A Deep Dive Examination of Redx Pharma Plc


Redx Pharma Plc Timeline

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use